Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend

Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend

Updated: 6 Nov 2025, 4:45 pm IST


What happened today (6 Nov)

  • The ₹6,632.3‑crore Groww IPO was fully subscribed on Day 2, with overall bids at 1.47x by mid‑afternoon; retail participation led the charge at 4.65x, NIIs at 1.88x, and QIBs at 0.20x (as per NSE data tracked during the session). [1]
  • Grey market premium (GMP) cooled through the day, fluctuating in the ~11–15% range versus the issue price. [2]
  • Zerodha’s Nithin Kamath congratulated Groww and said about 20% of Groww IPO applications are coming from Zerodha customers, underscoring crossover retail interest. [3]
  • A broad “Subscribe” chorus from top brokerages continued today, with some caution on valuation. [4]

Subscription status: the scoreboard at a glance

  • Overall: 1.47x (147%)
  • Retail: 4.65x (465%)
  • NII/HNI: 1.88x (188%)
  • QIB: 0.20x (20%)

Snapshot reflects live tallies captured around 3:24 pm IST on Day 2. Final end‑of‑day figures can vary once the exchanges publish consolidated data. [5]

A separate mid‑day cut from global wires also flagged the issue as “fully booked” by late morning today, driven by retail demand. [6]


Price band, lot size, structure, and key dates

  • Price band: ₹95–₹100 per share
  • Lot size:150 shares (₹15,000 for one lot at the upper band)
  • Issue size:₹6,632.30 crore, comprising a ₹1,060 crore fresh issue and an OFS of ₹5,572.30 crore by existing investors
  • Timeline: Closes Nov 7 (Fri); allotment expected Nov 10 (Mon); listing likely Nov 12 (Wed) on BSE & NSE
  • Anchor round:₹2,985 crore allocated to anchors on Nov 3 (≈29.84 crore shares at ₹100)
    These terms and dates were reiterated across exchange‑tracked updates and publisher reports today. [7]

Who’s going public?

The issuer is Billionbrains Garage Ventures Ltd, the parent of Groww, a mobile‑first investing platform spanning equities, F&O, mutual funds, and bonds. Recent coverage highlights Groww’s push beyond broking into wealth, commodities, and margin products—strategies expected to broaden revenue mix over time. [8]


Day‑2 talking points the market cared about

1) Retail momentum stayed strong

Retail investors continued to power the book, pushing the retail tranche near 5x by mid‑afternoon. That enthusiasm fits the pattern of retail‑led tech/fin‑serv listings through 2024–25 and often compensates for slower early bids from institutions. [9]

2) GMP cooled but remained positive

Unofficial grey‑market indicators trended ~₹11–₹15 above the upper band during the session, implying a ~11–15% indicative pop versus the issue price—but GMP is not an official data point and can change quickly into listing. [10]

3) Cross‑platform flow is real

Nithin Kamath (Zerodha) publicly applauded Groww’s IPO and noted that ~20% of Groww IPO applications are flowing from Zerodha customers—an unusual, friendly signal from a rival and a proof‑point of India’s deepening retail participation. [11]


What top brokerages said on Day 2

An ET Markets round‑up today captured a broad “Subscribe” consensus with a few neutral/valuation‑focused takes:

  • SBI Securities: Subscribe, citing leadership with ~12.6 million active NSE clients and strength in MF AUM/SIPs. [12]
  • Anand Rathi: Subscribe – Long Term; “fully priced” but backed by strong engagement and expansion into MTF/wealth/bonds. [13]
  • Kunvarji Wealth: Subscribe (M–L term); mobile‑first, scalable platform; in‑house tech a differentiator. [14]
  • Religare (WealthVia): Subscribe; calls Groww a “fintech infrastructure company in the making”; notes NBFC arm Groww Creditserv. [15]
  • SMIFS: Subscribe for long term; integrated digital ecosystem and rapid client growth. [16]
  • Master Capital Services (MasterTrust): Subscribe (LT); benefits from fintech penetration and largest user base by active NSE clients. [17]
  • Choice & Asit C. Mehta: Subscribe for long term; strong brand, retention, engagement; valuation “fully priced” vs peers. [18]
  • Bajaj Broking: Neutral (non‑rated); cites ~29.9x FY25 earnings valuation and strong retail presence. [19]
  • Angel One:Neutral; flags post‑issue P/E ~40.8x at the upper band as steep. [20]

How the numbers stack up

  • Scale & engagement: Brokerages point to Groww’s ~12.6 million active NSE clients and leadership in net new demat additions and active SIPs (June 2025), plus 100M+ cumulative app downloads—all inline with a retail‑first franchise. [21]
  • Valuation lens: Street notes range from ~29.9x FY25 (Bajaj Broking perspective) to ~40.79x post‑issue P/E (Angel One) at ₹100, reinforcing the “quality + premium” debate. [22]
  • Use of proceeds / structure: A majority OFS by existing investors with a ₹1,060 crore primary component; anchors already absorbed ₹2,985 crore at ₹100. [23]

GMP watch: why it matters—and why it doesn’t

GMPs offer a sentiment snapshot, not a forecast. Today’s 11–15% range signals healthy interest but has already softened from earlier days (e.g., ~14.75% yesterday). Liquidity, day‑3 QIB demand, and market tone can all shift this quickly before listing. [24]


Key dates you need to know

  • Day 3 (Final day to bid):Fri, Nov 7
  • Allotment:Mon, Nov 10
  • Listing:Wed, Nov 12
  • Lot size:150 shares (₹15,000 at ₹100)
    Keep an eye on QIB bids tomorrow; institutional demand typically firms up on the final day and often sets the tone for listing sentiment. [25]

FAQ (Investor quick‑read)

What is the Groww IPO price band and issue size?
₹95–₹100 per share; ₹6,632.30 crore (₹1,060 crore fresh + ₹5,572.30 crore OFS). [26]

How much was subscribed on Day 2?
Overall 1.47x by ~3:24 pm; Retail 4.65x, NII 1.88x, QIB 0.20x (intra‑day snapshot). [27]

What is the lot size and minimum investment?
150 shares; ₹15,000 at the upper band for one lot. [28]

What are brokerages recommending?
Mostly “Subscribe (long term)”, with valuation caution from some houses (e.g., Angel One neutral). [29]

When will Groww list?
Tentatively Nov 12, 2025, subject to timelines. [30]


Editorial note

This article summarizes today’s developments (6 Nov) around Groww’s IPO, combining exchange‑tracked subscription snapshots with publisher reports. Nothing here is investment advice. Please consult a SEBI‑registered advisor before investing.


Sources

  • Subscription, GMP & structure: Moneycontrol live updates and story on Day 2. [31]
  • Rival reaction & anchors; timeline: NDTV (Kamath’s post; allotment/listing schedule; anchor allocation details). [32]
  • Brokerage verdicts & metrics (active clients/SIP share): ET Markets Day‑2 recap of top‑10 broker views. [33]
  • Mid‑day confirmation of full subscription: Reuters update. [34]
Groww IPO - Latest GMP, anchor book and Update? | Groww IPO mauka ya dhokha? |

References

1. www.moneycontrol.com, 2. www.moneycontrol.com, 3. www.ndtv.com, 4. economictimes.indiatimes.com, 5. www.moneycontrol.com, 6. www.reuters.com, 7. www.moneycontrol.com, 8. www.reuters.com, 9. www.moneycontrol.com, 10. www.moneycontrol.com, 11. www.ndtv.com, 12. economictimes.indiatimes.com, 13. economictimes.indiatimes.com, 14. economictimes.indiatimes.com, 15. economictimes.indiatimes.com, 16. economictimes.indiatimes.com, 17. economictimes.indiatimes.com, 18. economictimes.indiatimes.com, 19. economictimes.indiatimes.com, 20. www.moneycontrol.com, 21. economictimes.indiatimes.com, 22. economictimes.indiatimes.com, 23. www.moneycontrol.com, 24. www.moneycontrol.com, 25. www.ndtv.com, 26. www.moneycontrol.com, 27. www.moneycontrol.com, 28. www.moneycontrol.com, 29. economictimes.indiatimes.com, 30. www.ndtv.com, 31. www.moneycontrol.com, 32. www.ndtv.com, 33. economictimes.indiatimes.com, 34. www.reuters.com

Stock Market Today

  • BigBear.ai Holdings (BBAI) Trades Above 12-Month Target; Analysts Weigh In
    November 6, 2025, 8:30 AM EST. BigBear.ai Holdings Inc (BBAI) recently traded at $5.23, topping the average 12-month target of $4.83 set by analysts. While the price sits above target, analysts span a wide range: one target at $3.50 and another at $6.00, with a standard deviation of $1.258, reflecting uneven views among the three contributing analysts. The move above the target raises questions about whether $4.83 is a stepping stone toward higher targets or a signal to take profits. Zacks coverage shows a mixed but constructive view: current ratings include two Strong Buy, two Hold, and no Sells, yielding an average Rating of 2.0 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell).
  • IREN Clears 12-Month Target, Trades at $76.41 as Target Range Runs From $24 to $142
    November 6, 2025, 8:28 AM EST. IREN Ltd (IREN) traded at $76.41 after overcoming the average 12-month target of $69.50. When a stock hits a target, analysts may downgrade on valuation or lift targets, depending on underlying fundamentals. Across Zacks' coverage there are 10 targets contributing to the average, with a low of $24 and a high of $142, producing a standard deviation of $32.613. The move above the average target fuels the "wisdom of crowds" thesis, prompting investors to decide whether $69.50 is a waypoint or the stock is now extended. Ratings show a tilt toward Strong Buys and Buys, with some Holds and a few Strong Sells less prevalent. Data sourced from Zacks via Quandl.
  • BHP Crosses Above Average Analyst Target of $67.33 as Shares Trade at $68.48
    November 6, 2025, 8:26 AM EST. Shares of BHP Group Ltd (BHP) moved to $68.48 and crossed above the average 12-month target of $67.33 cited by analysts. The move prompts reactions from analysts: potentially downgrades or renewed price targets, depending on underlying fundamentals. Zacks' coverage shows three targets feeding the average, with a low of $56 and a high of $87, and a standard deviation of $17.10. The piece highlights the 'wisdom of crowds' concept as investors weigh whether $67.33 is a stepping stone to higher valuations or a signal to trim positions. Current analyst ratings show 2 Strong Buys, 6 Holds, and no Sells, with an average rating of 2.5.
  • Qualys (QLYS) Clears 12-Month Analyst Target of $140.12; Shares Trade at $142.70
    November 6, 2025, 8:24 AM EST. Qualys, Inc. (QLYS) shares are trading at $142.70, topping the average 12-month analyst target of $140.12. When a stock hits an analyst target, the next move can be a downgrade or a raised target, depending on fundamental developments. The current picture shows 8 contributing targets in Zacks' coverage, with targets ranging from a low around $113 to a high of $175 and a standard deviation of about $22.71. The concept of a wisdom of crowds guides investors to weigh multiple views rather than relying on a single forecast. With QLYS above the average, investors may reassess whether $140.12 is a stepping stone to higher gains or a sign to take some chips off the table. Data from Zacks via Quandl.
  • Banco Santander Brasil Shares Edge Above 12-Month Target; Analysts Split on Next Move
    November 6, 2025, 8:22 AM EST. Banco Santander Brasil SA (BSBR) traded at $7.75, nudging above the average 12-month target of $7.72 set by analysts. With four targets in the Zacks coverage, the range spans from a low of $6.00 to a high of $10.00, and a standard deviation of $1.723. The move above the target sparks discussion whether this is a stepping stone to a higher price or a sign of overvaluation. The piece notes the wisdom of crowds behind the target, and highlights that investors should reassess fundamentals. The current analyst ratings show mostly Hold (3) with an average rating of 2.83 on a 1-5 scale, per Zacks via Quandl.
Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)
Previous Story

Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

Stocks Rally to Record Highs as Shutdown Looms – Dow and S&P Post Best September in 15 Years
Next Story

Stocks to Buy Today (Nov 6, 2025): ARM, AppLovin, Qualcomm, Tesla, Snap, AstraZeneca, Airbnb & More

Go toTop